Multidrug resistant pulmonary TB: Characteristics of drug resistance profiles of MBT in Ukraine

I. Liskina, S. Kuzovkova (Kiev, Ukraine)

Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Session: Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Session type: Thematic Poster Session
Number: 2618
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Liskina, S. Kuzovkova (Kiev, Ukraine). Multidrug resistant pulmonary TB: Characteristics of drug resistance profiles of MBT in Ukraine. Eur Respir J 2011; 38: Suppl. 55, 2618

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment of multidrug resistant pulmonary tuberculosis (MDR-TB) with different pattern of resistance
Source: Eur Respir J 2004; 24: Suppl. 48, 723s
Year: 2004

Multidrug resistant tuberculosis (MDR – TB) treatment outcomes in Iran
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004

Characteristics of the cases with primary multidrug resistance pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 652s
Year: 2005

Treatment results of multidrug resistant pulmonary tuberculosis (MDR-TB)
Source: Eur Respir J 2005; 26: Suppl. 49, 199s
Year: 2005

Impact of resistance to first-line and injectable drugs on treatment outcomes in MDR-TB
Source: Eur Respir J 2009; 33: 581-585
Year: 2009



Multi-drug resistant pulmonary tuberculosis in Belarus
Source: Annual Congress 2007 - Epidemiology of various lung diseases
Year: 2007


Lipid profile in patients with multidrug resistant pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 361s
Year: 2002

Outcome of multidrug resistant pulmonary tuberculosis
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010


Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Multidrug resistant tuberculosis in non HIV patients
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007


Drug resistance patterns in patients with multi-drug resistant tuberculosis (MDR – TB)
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012


Surgical treatment of multidrug resistant pulmonary tuberculosis (MDR-TB)
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009


Multidrug resistant tuberculosis: clinical aspects and management
Source: Eur Respir J 2001; 18: Suppl. 33, 235s
Year: 2001

Morphology of multi-drug resistant TB in the experiment
Source: Eur Respir J 2007; 30: Suppl. 51, 202s
Year: 2007

High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova
Source: Eur Respir J 2014; 43: 1132-1141
Year: 2014




Multi-drug resistance tuberculosis in Greece
Source: Eur Respir J 2003; 22: Suppl. 45, 344s
Year: 2003

Multidrug resistance after inappropriate tuberculosis treatment: a meta-analysis
Source: Eur Respir J 2012; 39: 1511-1519
Year: 2012



Treatment possibilities of multi-drug resistant (MDR) tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 525s
Year: 2003

Second and third line anti-tuberculosis drug's side effects during the treatment of patients with multidrug resistant tuberculosis (MDR TB)
Source: Eur Respir J 2003; 22: Suppl. 45, 555s
Year: 2003

Outcomes of patients with multidrug resistant tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 652s
Year: 2005